Basel Medical (BMGL) Short term Debt (2024 - 2025)

Basel Medical (BMGL) posted Short term Debt of $887764.0 for Q4 2025, down 45.52% sequentially from $1.6 million in Q2 2025, and up 81.44% YoY from $489275.0 in Q4 2024.

Basel Medical (BMGL) Short term Debt (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of Short term Debt data on file, last reported at $887764.0 in Q4 2025.

  • Quarterly Short term Debt rose 81.44% year-over-year to $887764.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $887764.0 (up 81.44% YoY) and the FY2025 annual result came in at $1.5 million, up 49.63% from the prior year.
  • Short term Debt declined to $887764.0 in Q4 2025 per BMGL's latest filing, from $1.6 million in the prior quarter.
  • The five-year high for Short term Debt was $1.6 million in Q2 2025, with the low at $489275.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Basel Medical 133.19 Mn 130.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 887,764.00
Jun 30, 2025 1.63 Mn
Dec 31, 2024 489,275.00
Jun 30, 2024 969,283.92